Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elfriede Nößner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Prostate|October 13, 2023
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancerLili Wang, Chen Lyu, Birgit Stadlbauer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 10, 2018
Fluorescent Polyvinylphosphonate Bioconjugates for Selective Cellular DeliveryChristina Schwarzenböck, Andreas Schaffer, Elfriede Nößner, et al.
Journal of Reproductive Immunology|September 26, 2021
Reduced frequency of perforin-positive CD8+ T cells in menstrual effluent of endometriosis patientsTimo Schmitz, Verena Hoffmann, Elisabeth Olliges, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Prostate|October 13, 2023
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancerLili Wang, Chen Lyu, Birgit Stadlbauer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 10, 2018
Fluorescent Polyvinylphosphonate Bioconjugates for Selective Cellular DeliveryChristina Schwarzenböck, Andreas Schaffer, Elfriede Nößner, et al.
Journal of Reproductive Immunology|September 26, 2021
Reduced frequency of perforin-positive CD8+ T cells in menstrual effluent of endometriosis patientsTimo Schmitz, Verena Hoffmann, Elisabeth Olliges, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
Pageof 1